NurOwn

BrainStorm Gears Up for Phase IIIb NurOwn Trial Amidst ALS Malaise
BioSpace
Mon, 07/22/24 - 11:29 am
BrainStorm Cell Therapeutics
FDA
ALX
NurOwn
stem cells
FDA gives nod to BrainStorm for ALS trial after Phase III flop
Clinical Trials Arena
Tue, 04/9/24 - 11:39 am
BrainStorm Cell Therapeutics
clinical trials
NurOwn
FDA
ALS
BrainStorm lays off 30% of staff, slimming down for yet another bid to get ALS cell therapy to market
Fierce Biotech
Tue, 10/24/23 - 09:53 am
BrainStorm Cell Therapeutics
layoffs
FDA
ALS
NurOwn
BrainStorm eyes FDA meeting to find path for rejected ALS drug after withdrawing application
Fierce Biotech
Wed, 10/18/23 - 11:20 am
BrainStorm Cell Therapeutics
ALS
FDA
NurOwn
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
BioSpace
Sun, 10/1/23 - 01:05 pm
FDA
BrainStorm Cell Therapeutics
NurOwn
Seelos Therapeutics
Takeda
Clene
FDA Adcomm Rejects BrainStorm’s ALS Therapy in Nearly Unanimous Vote
BioSpace
Wed, 09/27/23 - 11:21 pm
BrainStorm Cell Therapeutics
FDA
ALS
NurOwn
FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show
BioPharma Dive
Mon, 09/25/23 - 11:52 am
Brainstorm Cell Thearpaueics
ALS
stem cells
FDA
NurOwn
Following in Biogen's wake, BrainStorm analyzes effect of ALS cell therapy on biomarker
Fierce Biotech
Fri, 07/7/23 - 08:40 am
BrainStorm Cell Therapeutics
ALS
cell therapy
Biogen
NurOwn
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
FDA sets advisory meeting date for Brainstorm’s ALS cell therapy
BioPharma Dive
Tue, 06/6/23 - 04:11 pm
BrainStorm Cell Therapeutics
FDA
NurOwn
cell therapy
ALS
BrainStorm Secures FDA Adcomm for ALS Therapy NurOwn
BioSpace
Mon, 03/27/23 - 10:08 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
BrainStorm Vows to Push for Adcomm Meeting on NurOwn in ALS
BioSpace
Mon, 11/14/22 - 10:53 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
Not once, but twice: BrainStorm shares tumble as FDA again knocks back ALS drug
Fierce Biotech
Thu, 11/10/22 - 10:32 am
BrainStorm Cell Therapeutics
ALS
FDA
NurOwn
BrainStorm Brings MS Data on Heels of ALS BLA Announcement
BioSpace
Fri, 09/16/22 - 10:19 am
BrainStorm Cell Therapeutics
NurOwn
multiple sclerosis
MS
BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses
BioSpace
Mon, 08/15/22 - 10:17 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
clinical trials
NurOwn: A Study in the Complexity of ALS Trials
BioSpace
Tue, 05/4/21 - 10:44 pm
BrainStorm Cell Therapeutics
NurOwn
ALS
clinical trials
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
Stat
Tue, 06/26/18 - 11:59 am
BrainStorm Cell Therapeutics
right-to-try laws
ALS
clinical trials
NurOwn
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com
Mon, 07/18/16 - 09:45 am
BrainStorm Cell Therapeutics
stem cells
clinical trials
ALS
NurOwn
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Reuters
Mon, 01/5/15 - 10:33 am
BrainStorm Cell Therapeutics
stem cells
ALS
Lou Gehrig's disease
NurOwn
Brainstorm Cell Therapeutics Hits One-Year High Today
TheStreet.com
Fri, 01/2/15 - 10:25 am
BrainStorm Cell Therapeutics
stem cells
NurOwn
ALS
Lou Gehrig's disease

Pages